Comparison of efficacy between second line anti-androgen drugs for metastatic castration-resistent prostate cancer patients
碩士 === 臺北醫學大學 === 大數據科技及管理研究所 === 106
Main Authors: | Po-Jung Su, 蘇柏榮 |
---|---|
Other Authors: | Yung-Chun Chang |
Format: | Others |
Language: | zh-TW |
Published: |
2018
|
Online Access: | http://ndltd.ncl.edu.tw/handle/mq9vtm |
Similar Items
-
Determining the efficacy of novel anti-androgens in models of castrate resistant prostate cancer
by: O'Neill, Daniel James
Published: (2014) -
Novel Treatment Strategy Using Second-Generation Androgen Receptor Inhibitors for Non-Metastatic Castration-Resistant Prostate Cancer
by: Doo Yong Chung, et al.
Published: (2021-06-01) -
Androgen Receptor Targeted Therapy + Radiotherapy in Metastatic Castration Resistant Prostate Cancer
by: Maria Massaro, et al.
Published: (2021-09-01) -
Efficacy of Androgen Deprivation Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Docetaxel-Based Chemotherapy
by: Kyungchan Min, et al.
Published: (2020-04-01) -
Cabazitaxel: a novel second-line treatment for metastatic castration-resistant prostate cancer
by: Channing J Paller, et al.
Published: (2011-03-01)